To β or Not to β : How Important Is β-Catenin Dependent and Independent WNT Signaling in CLL?
WNT pathways play an important role in cancer development and progression, but WNT pathways can also inhibit growth in melanoma, prostate, and ovarian cancers. Chronic lymphocytic leukemia (CLL) is known for its overexpression of several WNT ligands and receptors. Canonical WNT signaling is β-catenin-dependent, whereas non-canonical WNT signaling is β-catenin-independent. Research on WNT in CLL focuses mainly on non-canonical signaling due to the high expression of the WNT-5a receptor ROR1. However, it was also shown that mutations in canonical WNT pathway genes can lead to WNT activation in CLL. The focus of this review is β-catenin-independent signaling and β-catenin-dependent signaling within CLL cells and the role of WNT in the leukemic microenvironment. The major role of WNT pathways in CLL pathogenesis also makes WNT a possible therapeutic target, directly or in combination with other drugs.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
---|---|
Enthalten in: |
Cancers - 15(2022), 1 vom: 28. Dez. |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Urbanek, Karol D [VerfasserIn] |
---|
Links: |
---|
Themen: |
---|
Anmerkungen: |
Date Revised 11.01.2023 published: Electronic Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.3390/cancers15010194 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM351232826 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM351232826 | ||
003 | DE-627 | ||
005 | 20231226050851.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231226s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.3390/cancers15010194 |2 doi | |
028 | 5 | 2 | |a pubmed24n1170.xml |
035 | |a (DE-627)NLM351232826 | ||
035 | |a (NLM)36612190 | ||
035 | |a (PII)194 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Urbanek, Karol D |e verfasserin |4 aut | |
245 | 1 | 3 | |a To β or Not to β |b How Important Is β-Catenin Dependent and Independent WNT Signaling in CLL? |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 11.01.2023 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a WNT pathways play an important role in cancer development and progression, but WNT pathways can also inhibit growth in melanoma, prostate, and ovarian cancers. Chronic lymphocytic leukemia (CLL) is known for its overexpression of several WNT ligands and receptors. Canonical WNT signaling is β-catenin-dependent, whereas non-canonical WNT signaling is β-catenin-independent. Research on WNT in CLL focuses mainly on non-canonical signaling due to the high expression of the WNT-5a receptor ROR1. However, it was also shown that mutations in canonical WNT pathway genes can lead to WNT activation in CLL. The focus of this review is β-catenin-independent signaling and β-catenin-dependent signaling within CLL cells and the role of WNT in the leukemic microenvironment. The major role of WNT pathways in CLL pathogenesis also makes WNT a possible therapeutic target, directly or in combination with other drugs | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Review | |
650 | 4 | |a ROR1 | |
650 | 4 | |a WNT | |
650 | 4 | |a chronic lymphocytic leukemia | |
700 | 1 | |a Stilgenbauer, Stephan |e verfasserin |4 aut | |
700 | 1 | |a Mertens, Daniel |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Cancers |d 2009 |g 15(2022), 1 vom: 28. Dez. |w (DE-627)NLM198667213 |x 2072-6694 |7 nnns |
773 | 1 | 8 | |g volume:15 |g year:2022 |g number:1 |g day:28 |g month:12 |
856 | 4 | 0 | |u http://dx.doi.org/10.3390/cancers15010194 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 15 |j 2022 |e 1 |b 28 |c 12 |